Status: current, Defined. Date: 30-Apr 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2324971000168118 | adalimumab 20 mg / 0.2 mL injection, 0.2 mL syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2324981000168115 | adalimumab 20 mg/0.2 mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| adalimumab 20 mg/0.2 mL injection, syringe | Is a | adalimumab | true | Inferred relationship | Some | ||
| adalimumab 20 mg/0.2 mL injection, syringe | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| adalimumab 20 mg/0.2 mL injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| adalimumab 20 mg/0.2 mL injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 1966022109 | |
| adalimumab 20 mg/0.2 mL injection, syringe | has Australian BoSS | adalimumab | true | Inferred relationship | Some | 1966022108 | |
| adalimumab 20 mg/0.2 mL injection, syringe | has intended active ingredient | adalimumab | true | Inferred relationship | Some | 1966022108 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes | has MPUU | True | adalimumab 20 mg/0.2 mL injection, syringe | Inferred relationship | Some | 1 |
| Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | Is a | True | adalimumab 20 mg/0.2 mL injection, syringe | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR